Authors: Azadeh Abravan1, Dora Correia2, Anne Gasnier3, Stella Shakhverdian4, Tirza van der Stok4, Jenny Bertholet5, Ludwig Dubois6, Barbara Jereczek-Fossa7, Matteo Pepa8, Mateusz Spalek9, Steven Petit10, Pierfrancesco Franco11, Violet Petit-Steeghs4
1The University of Manchester and The Christie Hospital, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health and Department of Radiotherapy Related Research, MANCHESTER, United Kingdom; 2Cantonal Hospital Aarau, Department of Radiation Oncology, Aarau, Switzerland; 3Centre Henri Becquerel, Department of Radiotherapy, Rouen, France; 4Erasmus University, Erasmus School of Health Policy & Management Health Care Governance, Rotterdam, The Netherlands; 5Bern University Hospital, and University of Bern, Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital , Bern, Switzerland; 6Maastricht University, The M-Lab, Dept. of Precision Medicine, GROW – School for Oncology and Reproduction, Maastricht , The Netherlands; 7University of Milan, Department of Oncology and Hemato-oncology, Milan, Italy; 8European Institute of Oncology IRCCS, Division of Radiation Oncology, IEO, Milan, Italy; 9Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland; 10Erasmus MC Cancer Institute, Erasmus University Medical Center, Department of Radiotherapy, Rotterdam, The Netherlands; 11University of Eastern Piedmont, Department of Translational Medicine, Novara, Italy